<!doctype html>

<html lang="en">
<head>
  <meta charset="utf-8">
  <title>Home</title>
  <meta name="description" content="Bolden Therapeutics website">
  <meta name="author" content="Sam Oliphant">
  <link rel="stylesheet" type="text/css" href="assets/css/styles.css" />
  <link rel="stylesheet" type="text/css" href="assets/css/nav.css" />
  <link rel="stylesheet" type="text/css" href="assets/css/team.css" />
  <link rel="stylesheet" type="text/css" href="assets/css/home.css" />
  <link rel="shortcut icon" href="assets/img/favicon.png">
</head>
<body>
  <div class="main">
    <div class="top-part">
      <nav class="navbar">
  <div class="navbar-container">
    <a href="index.html"><img src="assets/img/bolden-logo-mini.svg" class="navbar-logo"></a>
    <div class="navbar-links">
      
      <div class="navbar-item active">
        <a class="navbar-link" href="index.html">Home</a>
      </div>
      
      <div class="navbar-item">
        <a class="navbar-link" href="events.html">Events</a>
      </div>
      
      <div class="navbar-item">
        <a class="navbar-link" href="team.html">Team</a>
      </div>
      
      <div class="navbar-item">
        <a class="navbar-link" href="press.html">Press</a>
      </div>
      
    </div>
  </div>
</nav>

      <div class="contents">
      <div class="home">
  <div class="home-intro">
    <h2>Who are we?</h2>
    <p>Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s disease and ischemic stroke.</p>
  </div>
  
<div class="home-pic" style="background-image: url(assets/img/science/computer-brain.jpeg); text-align: left;">
  <div class="home-background-dim"></div>
  <div class="home-pic-text">
    <h2>Overview</h2>
    <p>Bolden Therapeutics is a preclinical-stage biotechnology company developing compounds to treat serious neurological and neurodegenerative diseases.</p>  
  </div>
</div>

<div class="home-pic" style="background-image: url(assets/img/science/tech-brain.jpeg); text-align: center;">
  <div class="home-background-dim"></div>
  <div class="home-pic-text">
    <h2>Background</h2>
    <p>Our research focuses on pathological states in which the formation of new neurons in the adult brain – termed “adult neurogenesis” (AN) – declines. Diminished AN can contribute to cognitive dysfunction and memory loss in numerous diseases. In addition, AN has been implicated as important for functional recovery following traumatic brain injury (TBI) and ischemic stroke. Intuitively, augmenting AN represents an attractive approach for therapy in multiple indications.</p>  
  </div>
</div>

<div class="home-pic" style="background-image: url(assets/img/science/brains.jpeg); text-align: right;">
  <div class="home-background-dim"></div>
  <div class="home-pic-text">
    <h2>Target Indications</h2>
    <p>Given the multitude of potential clinical applications of a pro-neurogenic therapy, there are several patient populations that our approach may help treat. These include but are not limited to: Alzheimer’s disease and related dementias, treatment-resistant depression, post-traumatic stress disorder, stroke recovery, traumatic brain injury.</p>  
  </div>
</div>

</div>

      </div>
    </div>
    <footer class="footer">
      <p>Contact Us</p>
      <p><a href="mailto: jpage@boldentherapeutics.com">jpage@boldentherapeutics.com</a></p>
      <p>225 Dyer Street, Floor 2</p>
      <p>Providence, RI, 02903</p>
    </footer>
  </div>
  <script src="assets/js/index.js"></script>
</body>
</html>

